Pfizer slashes 2022 earnings outlook despite strong first quarter Covid vaccine and antiviral sales
Pfizer slashes 2022 earnings outlook despite strong first quarter Covid vaccine and…
Merck sold $3.2 billion of its Covid oral antiviral treatment, driving first-quarter revenue growth
Merck sold $3.2 billion of its Covid oral antiviral treatment, driving first-quarter…
Business News: Merck asks FDA to authorize antiviral Covid pill for emergency use
Merck asks FDA to authorize antiviral Covid pill for emergency use :…